Descriptions of governance and operational groups overseeing and implementing the RADxⓇ Tech program. More information about governance of the RADx Tech program and all RADx Initiative programs can be found on the NIH RADx Initiative page.
National Institute of Biomedical Imaging and Bioengineering - Oversees Rapid Acceleration of Diagnostics (RADx) Tech program and drives strategic objectives and decision-making.
- Leadership - Sets overall objectives of RADx Tech and charts direction, main communications channel to National Institutes of Health (NIH) leadership
- Programs - Day-to-day oversight of Consortia for Improving Medicine with Innovation and Technology’s (CIMIT) management of RADx Tech; provides technical expertise and leadership to the Point-of-care Technology Research Network (POCTRN).
- Communications and Policy - Develops and implements communications and policy strategy.
- Partnerships – Identifies and manages partnerships with federal agency and industry partners
Consortia for Improving Medicine with Innovation & Technology (CIMIT) - Monitors the effectiveness of the approach being taken by the Network and evaluates the progress of POCTRN.
- Test Validation Core - Supports and conducts early and independent validation of prototype technologies.
- Clinical Trials Core - Supports and conducts clinical studies to evaluate diagnostic test performance for large-scale viral detection.
- Deployment Core - Anticipates supply needs and manufacturing requirements for building scale-up capacity through partnerships.
POCTRN Independent Expert Board (IEB) – Monitors the effectiveness of the approach being taken by the Network and evaluates the progress of POCTRN.
Biomedical Advanced Research and Development Authority (BARDA) and Food and Drug Administration (FDA) - Provide scientific, technical, and operational support to help RADx awardees mature, scale, and commercialize technologies.
